NCT06325618 Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome
| NCT ID | NCT06325618 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Turner Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-01-08 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-01-08 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
100 women with karyotype verified TS, previously examined at 4 study visits during a 19-year period will be asked to participate in a 5th study visit. Healthy age-matched females will be included as controls in a ratio 2:1. The aim is to examine and quantify the cardiovascular and lymphatic system in women with TS. The investigators will study a possible causal mechanism between the known pathologic phenotype and alterations in these systems to understand, prevent or treat the life-threatening complications in TS.
Eligibility Criteria
Inclusion Criteria: * Turner Syndrome Exclusion Criteria: * pregnancy * contraindications for MRI
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06325618 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 100 Years, studying Turner Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06325618 currently recruiting?
Yes, NCT06325618 is actively recruiting participants. Contact the research team at libals@clin.au.dk for enrollment information.
Where is the NCT06325618 trial being conducted?
This trial is being conducted at Aarhus N, Denmark.
Who is sponsoring the NCT06325618 clinical trial?
NCT06325618 is sponsored by University of Aarhus. The trial plans to enroll 150 participants.